Download FREE Report Sample
Download Free samplePoractant Alfa is a natural extract, phospholipids account for 90% of the dry weight, most of which are phosphatidyl choline (PC), the PC with surface activity is phosphatidyl choline dipalmitic acid, the rest of the phospholipids also include phosphatidyl ethanolamine, phosphatidyl serine, phosphatidyl inositol and sphingomyelin.In addition, there are two kinds of sp-b and sp-c, which show the active substance (PS) specific proteins.Porcine pneumophylline injection for the treatment and prevention of respiratory distress syndrome (RDS) in premature infants.
Poractant Alfa Market aims to provide a comprehensive presentation of the global market for Poractant Alfa, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poractant Alfa. Poractant Alfa Market contains market size and forecasts of Poractant Alfa in global, including the following market information:
Global Poractant Alfa Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Poractant Alfa Market Sales, 2018-2023, 2024-2030, (K Doses)
Global top five Poractant Alfa companies in 2022 (%)
The global Poractant Alfa market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Rapid Dosing Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Poractant Alfa include Chiesi, Douglas Pharma, Takeda, Mylan and Piramal, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Poractant Alfa manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Poractant Alfa Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Doses)
Global Poractant Alfa Market Segment Percentages, by Type, 2022 (%)
Rapid Dosing
Microdosing
Global Poractant Alfa Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Doses)
Global Poractant Alfa Market Segment Percentages, by Application, 2022 (%)
Salvage Treatment
Prevention of Respiratory Distress Syndrome (RDS)
Global Poractant Alfa Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Doses)
Global Poractant Alfa Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Poractant Alfa revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Poractant Alfa revenues share in global market, 2022 (%)
Key companies Poractant Alfa sales in global market, 2018-2023 (Estimated), (K Doses)
Key companies Poractant Alfa sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Chiesi
Douglas Pharma
Takeda
Mylan
Piramal
Outline of Major Chapters:
Chapter 1: Introduces the definition of Poractant Alfa, market overview.
Chapter 2: Global Poractant Alfa market size in revenue and volume.
Chapter 3: Detailed analysis of Poractant Alfa manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Poractant Alfa in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Poractant Alfa capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy